GE HealthCare Technologies Bilan de santé

Santé financière contrôle des critères 3/6

GE HealthCare Technologies possède un total de capitaux propres de $8.5B et une dette totale de $10.3B, ce qui porte son ratio d'endettement à 121.2%. Son actif total et son passif total sont $33.9B et de $25.3B. L'EBIT de GE HealthCare Technologies est $3.0B ce qui fait que son ratio de couverture des intérêts 5.7. Elle dispose de liquidités et de placements à court terme de $3.6B.

Informations clés

121.2%

Ratio d'endettement

US$10.31b

Dette

Ratio de couverture des intérêts	5.7x
Argent liquide	US$3.55b
Fonds propres	US$8.51b
Total du passif	US$25.34b
Total des actifs	US$33.86b

Mises à jour récentes de la santé financière

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

May 21

Recent updates

From Spin-Off To Standout: GE HealthCare Is Pretty Impressive

Oct 30

GE HealthCare: The Image Of More Upside Is Very Real

Sep 18

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

Sep 05

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies' Roar Higher Isn't Over Yet

Mar 09

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de GEHC ( $10.6B ) dépassent ses passifs à court terme ( $8.7B ).

Passif à long terme: Les actifs à court terme de GEHC ( $10.6B ) ne couvrent pas ses passifs à long terme ( $16.7B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de GEHC ( 79.5% ) est considéré comme élevé.

Réduire la dette: Données insuffisantes pour déterminer si le ratio d'endettement de GEHC a diminué au cours des 5 dernières années.

Couverture de la dette: La dette de GEHC est bien couverte par le flux de trésorerie opérationnel ( 20.2% ).

Couverture des intérêts: Les paiements d'intérêts de GEHC sur sa dette sont bien couverts par l'EBIT ( 5.7 x couverture).

GE HealthCare Technologies Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

Recent updates

Third quarter dividend of US$0.035 announced

GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

GE HealthCare Technologies Inc. Reiterates Earnings Guidance for the Year 2024

GE Healthcare Announces Publication of Data from A Two-Phase Pilot Study Conducted with Cleveland Clinic in the Peer-Reviewed Journal of Clinical Anesthesia

GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies Inc. Updates Earnings Guidance for the Full Year 2024

Third quarter 2024 earnings: EPS exceeds analyst expectations

From Spin-Off To Standout: GE HealthCare Is Pretty Impressive

GE HealthCare Technologies Inc. Announces Hospital Pulse, the Newest Tile for Its Command Center Software Platform

GE HealthCare Introduces Easy-To-Use, Easy-To-Learn, Easy-To-Appoint Versana Premier Multi-Purpose Ultrasound System

Upcoming dividend of US$0.03 per share

GE Healthcare Accelerates Artificial Intelligence Adoption with New Offering to Advance Enterprise Imaging

GE HealthCare Technologies Inc. to Report Q3, 2024 Results on Oct 30, 2024

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease

Second quarter dividend of US$0.03 announced

GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint

GE HealthCare: The Image Of More Upside Is Very Real

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

GE HealthCare Technologies Inc. Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments At the Point of Care At ESC 2024

GE HealthCare Announces the Publication of the MASTER Trial Results in the Peer-Reviewed Journal Anesthesia and Analgesia

Insider recently sold US$1.6m worth of stock

GE HealthCare Q2 Earnings Recap (Rating Downgrade)

Second quarter 2024 earnings: EPS exceeds analyst expectations

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q2, 2024 Results on Jul 31, 2024

GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities

First quarter dividend of US$0.03 announced

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

GE Healthcare Names Adam Holton as Chief People Officer

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

President & CEO of Imaging notifies of intention to sell stock

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies' Roar Higher Isn't Over Yet

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines